Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) often escapes T cell–mediated immunity through impaired major histocompatibility complex class I (MHC-I) antigen presentation, contributing to its limited responsiveness to T cell–based immunotherapies. Because natural killer (NK) cells are...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2026-03-01
|
| Schriftenreihe: | Journal of Biological Engineering |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13036-026-00651-y |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
